Purpose: This study examined the role of trace elements in osteoporosis by comparing the trace-element concentrations in bone and the radiographic bone density and bone mineral density (BMD) of patients with osteoporotic femur fractures and osteoarthritis.
Introduction
Osteoporosis is a metabolic bone disease characterized by increased bone fragility due to decreased bone mass and altered bone microstructure, and is associated with high mortality, morbidity, and treatment costs. 1 The World Health Organization reported that 35% of the women in the US older than 65 years had osteoporosis in 1994. 2 The most dreaded complication of osteoporosis is bone fracture, particularly of the hip. In 1990, 1.3 million hip fractures were reported worldwide, and this figure is expected to double by 2025 and to reach 4.5 million by 2050. 3 The relationship between trace elements and the etiology of osteoporosis is intriguing. The role of alterations in such trace elements as magnesium, copper, zinc, manganese, cadmium, and lead in the development of osteoporosis and the effects of treating mineral profiles on osteoporosis have yet to be fully elucidated.
Magnesium, a ubiquitous element in various organ systems, is thought to play a role in the mineral metabolism of both soft and hard tissues. It mimics the actions of Ca in transport and mineralization processes, and is required for normal Ca absorption. Its roles in bone metabolism and in the development of metabolic bone disease are not fully understood. Furthermore, whether Mg deficiency results in osteoporosis is unknown, with conflicting reports on the Mg content of osteoporotic bone. 4 Zinc is a component of the cell nucleus, mitochondria, cytoplasm, and plasma membrane, and is involved in the synthesis of several metalloenzymes. [5] [6] [7] It is an essential component of enzymes involved in transcription, translation, and nucleic acid synthesis, which have important roles in the metabolic activity of bone. 5 In addition, bone zinc content is decreased postmenopausally, and with aging and skeletal unloading, suggesting a role in bone disorders. 8 Therefore, this study compared the trace-element concentrations in bone and the radiographic bone density and bone mineral density (BMD) of two groups of patients: those undergoing partial hip prosthesis due to an osteoporotic proximal femoral fracture, and those undergoing total hip arthroplasty due to osteoarthritis. 
Patients and methods Patients

surgical sampling
All patients had prosthetic hip replacements. During the surgical procedure, the soft tissues surrounding the femoral head were displaced, after which the femoral head and neck were extracted from the acetabulum manually in all patients to avoid any metal contamination. Then, the sample was cleaned using 1,000 mL of physiological saline and stored at -70°C for biochemical and radiological examinations.
Assessments radiological assessment of bone tissue samples
All of the frozen samples from the patient and control groups (ie, the proximal femur bone samples) were examined with 1.25 mm-thick cross sections using a LightSpeed ® 16-multislice computed tomography device (GE Healthcare, Waukesha, WI, USA) in a single session. Reformatted images were obtained with an Infinitt (Phillipsburg, NJ, USA) picture-archiving and communication-system viewer. The tomographic densities were calculated using the Hounsfield scale at three different points limited to spongy bone. With this scale, the attenuation factor for the X-rays diffusing through the tissues is calculated numerically to represent each pixel. The numbers are arranged on a scale between +1,000 and -1,000 where the attenuation value of water is zero.
Biochemical assessment of bone tissue samples
The bone specimens obtained from the patients were transferred to the laboratory and dried in an oven at 110°C until a constant weight was reached. This procedure was used to determine the water content (gravimetric method). Dried samples were ground in an agate mortar. Bone material was mineralized using wet digestion in a Velp Scientifica mineralizer (Usmate Velate, Italy). 9, 10 The analytical ash sample (approximately 1 g) was digested in 2 cm 3 of spectrally pure HNO 3 (V) (Suprapur ® ; Merck Millipore, Billerica, MA, USA). The bone samples were dissolved in 10 mL of concentrated HNO 3 using a microwave oven. Then, the samples were diluted to a volume of 25 mL using distilled water for inductively coupled plasma mass spectrometry (ICP-MS).
Determination
A PerkinElmer (Norwalk, CT, USA) model A Analyst 800 flame atomic absorption spectrometer equipped with a deuterium background-correction system and an airacetylene burner was used to determine Ca(II) and Mg(II) at wavelengths of 422.7 and 285.2 nm, respectively, using standard working parameters: spectral bandwidth 0. 
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Trace elements in osteoporosis acetylene flow rate 1.4 L⋅min -1 , and nebulizer flow rate 10 mL⋅min -1 . Then, 100 mL of each the dissolved bone samples was diluted using 10 mL of 1 M HNO 3 for magnesium determination. To measure calcium, 50 mL of 2% lanthanum solution was added to 50 mL of the dissolved bone sample to eliminate the risk of a faulty measurement, due to the high phosphate content of the bone. Then, the volumes were made up to 10 mL for flame atomic absorption spectrometry.
For ICP-MS, an Agilent 7500A (Agilent Technologies, Santa Clara, CA, USA) was used with a Consort (Turnhout, Belgium) model C533 pH meter combined with a glass electrode. For each dissolved bone sample, a 10 mL sample was obtained and neutralized using 1 M NaOH. Then, the pH was adjusted to 4.5 with a magnetic mixer following an optimized procedure. Next, 1 mL of 1% ammonium pyrrolidine dithiocarbamate (APDC) solution was added to each sample and mixed for 10 minutes. The sample solution was then transferred to a separatory funnel. The metal-APDC chelate was extracted by shaking the mixture for 2 minutes with 5+5 mL of methyl isobutyl ketone. The two phases were allowed to separate, and then the organic phase was transferred to another separatory funnel. To this organic phase, 10 mL of 2 M HNO 3 was added and mixed thoroughly, and then the metal-APDC chelate was back-extracted from the methyl isobutyl ketone into 2 M HNO 3 . To determine the metal concentrations, the aqueous phase was analyzed using ICP-MS. For each sample, two or three repetitions were performed, and statistical analysis was used to average the data, which were expressed as micrograms per gram dry weight (dw). In order to verify the accuracy of the procedure, the method for certified reference materials was used (CRM-1486). 10 The results are shown in Tables 1 and 2 .
Bone mineral-density measurement
In both patient groups, BMD, Z-scores, and T-scores were measured in the unaffected hip with dual-energy X-ray absorptiometry (DEXA) using a QDR-4500A (Hologic, Bedford, MA, USA) within the first week after surgery.
DEXA was performed with the patient in a supine position, with the hip joint rotated 15° internally. Osteophytes and sclerotic margins were excluded from the measurement.
statistical analyses SPSS 21.0 (IBM, Armonk, NY, USA) was used for the statistical analyses. Descriptive statistics are presented as means and standard deviation. The homogeneous distribution of the groups was tested using the KolmogorovSmirnov and Shapiro-Wilk tests. Variables with normal distributions were evaluated using the independent t-test, while those with abnormal distributions were tested using the Mann-Whitney U test. The associations among variables were assessed using Spearman's and Pearson's correlation analyses. A P-value 0.05 was considered to indicate statistical significance.
Results
The fracture group was significantly older than the osteoarthritis group (mean age 77.4±8.6 versus 64.6±6.1 years, P0.001). The groups did not differ with regard to sex distribution (male:female ratio 9:21 in both groups, P=1.000).
The patients in the fracture group all underwent a partial hip arthroplasty; this was for intertrochanteric fractures in ten patients and for femoral neck fractures in 20 patients. All patients in the osteoarthritis group underwent total hip arthroplasty. The two groups are compared in All of the DEXA findings were significantly worse in the fracture group compared to the osteoarthritis group (T-score, -3±1.2 versus -1.1±0.8, P0.05; Z-score, -1.13±1.2 versus 0.05±0.8, P0.05; and BMD, 0.6±0.1 versus 0.8±0.09, P0.001); however, the groups did not differ radiologically in femoral neck density assessed using the Hounsfield scale (Table 4 ). According to the Spearman analysis, Ca (r=0.49), When sex effects were evaluated, Ca, Mg, T-scores, Z-scores, and BMD were significantly lower in the fracture group for females, while Zn levels were included in this list for males. In the fracture group, females had significantly lower Zn levels than males (t=-2.146, P=0.041); interestingly, Mn levels were significantly higher in females (U=43,
P=0.002).
Although the relationship between Ca/Mg and Zn levels (r=0.015, P0.05) was not significant, there was a strong correlation between Ca/Mg (r=0.844) levels in the fracture group and Ca/Zn (r=0.32) and Zn/Mg (r=0.438) when evaluated in both groups. In the Spearman analysis, despite positive correlations between Fe, K, Cr, Pb, and As levels and the presence of fracture, they were not significant (P0.05).
Discussion
This study compared the bone mineral concentrations, mineral density, and radiological density in patients with femoral fractures or osteoarthritis. As expected, patients with bone fractures had lower BMD, T-scores, and Z-scores than those with osteoarthritis. Similarly, the calcium concentration in the bones with fractures was lower. In addition, the concentrations of a large number of trace elements were examined, with Ca, Mg, and Zn levels being lower in cases with femoral fractures, as shown by DEXA. However, there were no significant differences in the other trace element levels and tomographic Hounsfield-unit levels. We are convinced that this situation would change using quantitative computed tomography and increasing the number of subjects.
Several clinical studies have reported chronic Mg deficiency in postmenopausal women with osteoporosis. [11] [12] [13] [14] [15] [16] Nielsen found a reduced concentration of ionized calcium due to Mg deficiency, and concluded that Mg is required for optimal Ca metabolism and that elderly males and postmenopausal females need Mg to prevent the severe bone loss that is common in these populations. 17 Increased numbers of osteoclasts, decreased osteoblastic function, and accelerated bone mineralization have been observed in association with magnesium Mann-Whitney U test. Abbreviations: AM, arithmetic mean; SD, standard deviation; DEXA, dual-energy X-ray absorptiometry; BMD, bone mineral density. 
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Karaaslan et al deficiency, suggesting that altered metabolic turnover and mineralization in bone causes bone fragility. 18, 19 In our study, subjects with femoral neck fractures had significantly lower bone Mg concentrations than those with osteoarthritis, and there was a negative correlation between age and Mg content in the overall study group. In addition, there was a positive correlation between Mg levels and BMD. Collectively, these data support the suggestions that low Mg increases the risk of fracture.
Calhoun reported increased zinc uptake during bone healing in rats. 20 In experimental animal models, Zn deficiency has been associated with altered osteoblastic activity and decreased synthesis of collagen, chondroitin sulfate, and alkaline phosphatase. 21 Despite conflicting data on the bone zinc concentration in patients with osteoporosis, there is a consensus regarding the important role of Zn in bone metabolism. [22] [23] [24] [25] Steidl and Ditmar reported lower Zn concentrations in patients with senile or postmenopausal osteoporosis, suggesting an association between zinc and magnesium in patients with osteoporosis. 26 To investigate the role of Zn in osteoporosis, Matarán Pérez et al explored the relationship between the oral intake of Zn through nutrition and urinary and serum levels of Zn, finding no significant difference in serum Zn levels between osteoporotic and nonosteoporotic subjects. 27 A new finding -that the zinc status of osteoporotic patients is significantly different from that of patients with osteoarthritis -supports the view that these two conditions rarely occur in the same individual. 28 In our study, the Zn content of bone was marginally significantly lower in fracture patients compared to osteoarthritis patients, but there was no correlation between Zn and BMD. Considering the contradictory data, further work is necessary to better define the role of Zn in the development of osteoporosis.
Several studies have looked at the association between trace-element intake and bone parameters, in addition to the possible benefits of supplementation with trace elements. In a study of 159 females, Angus et al found that forearm BMD was positively correlated with Fe, Zn, and Mg intake, and suggested that nutritional factors other than calcium play a role in the formation of bone mass. 29 Hyun et al reported a positive correlation between dietary Zn intake, plasma Zn concentration, and BMD. 30 Similarly, supplementation with Zn and Cu has been found to decrease bone loss in postmenopausal females, and supplementation with Ca paradoxically resulted in reduced absorption of Zn and Cu. 31, 32 Cournot and Hercberg underscored the role of trace elements in the prevention and treatment of osteoporosis, focusing on the importance of consuming Mg-rich nutrients, as well as milk and milk products, starting from childhood. 33 Tranquilli et al reported lower intakes of Ca, P, and Mg in 194 osteoporotic females compared to controls, and found a correlation between these elements and BMD. 34 They pointed out the importance of appropriate counseling for nutritional supplementation before and after menopause, enriching the diet with these elements, and comprehensive nutritional assessment in the treatment of postmenopausal osteoporosis. Gür et al reported lower Zn and Mg in osteoporotic subjects, and that the addition of trace elements to the diet was efficacious in ameliorating the deficits. They also recommended the use of trace-element assessment in osteoporotic patients with normal Ca or P levels. 35 Sojka and Weaver observed a significant increase in bone density and a preventive effect on fractures after 2 years of treatment with Mg(OH) 2 in a group of postmenopausal females. 36 In another study, following treatment with Mg for 1 year, an improvement in BMD was detected in comparison with controls. 37 Steidl and Ditmar administered only Mg lactate to 60 patients with osteoporosis, and observed improvements in pain and spinal movements and no progression in kyphosis or X-ray findings at follow-up assessments at 6 months, 1 year, and 2 years. 38 A decrease in trace elements with increasing age has been reported. Zaichick and Zaichick examined the trace elements in human iliac bone, and observed a significant decrease in the Ca, Mg, and P contents with increasing age. 39 This finding is partially in agreement with our results, which suggested that Ca, Mg, and BMD decreased with age. Therefore, we believe that enriching the diet with trace elements should be considered in elderly populations.
Our study suggested that in the fracture group, the sex effect was important. Zn levels were significantly lower in females than males, while Mn levels were significantly higher. Contrary to previous reports, we detected no other correlation or Ca:Mg-ratio variation according to levels of other trace elements. [40] [41] [42] The determination of trace elements in living organisms, including bone tissue, is one of the main means by which bioindicators can be used to assess environmental pollution indirectly. Trace elements may not only be bioindicators of environmental exposure to metals in humans but also critical determinants of fracture risk as a result of osteoporosis. Osteoporosis and the occurrence of fractures in an elderly population are complex multifactorial situations, potentially involving genetic, metabolic, and environmental factors. It is perhaps not surprising that no strong association between elemental concentrations and the tendency to 
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Trace elements in osteoporosis fracture was found. Our results support the suggestions of others: that there are systemic differences between the bones of patients with fractures and those of age-matched nonfracture patients, and that other factors determine the risk of fracture. However, we cannot exclude the possibility that trace-element accumulation at specific localized sites, eg, bone-mineralization fronts or within osteoblasts, causes problems, nor can we exclude the possibility that the causes of fracture differ among patients.
Conclusion
We found decreased bone Ca, Mg, and Zn contents in patients with osteoporotic fractures compared to subjects with osteoarthritis. In addition, Ca, Mg, and Zn decreased with age, in parallel with a reduced BMD. These results suggest that these trace elements play an important role in bone breakdown/synthesis. Although the exact role of these trace elements is still unclear, the addition of milk, milk products, or trace element-rich food sources to the diet starting from childhood and supplementation of osteoporotic patients with trace elements in addition to other therapeutic agents seems a reasonable approach. Further studies of the role of trace elements in the etiology and treatment of osteoporosis are warranted.
